Funder: National Institutes of Health (NIH)
Due Dates: November 17, 2025
Funding Amounts: Award size and duration vary; contact program for details. No cost-sharing required.
Summary: Supports small businesses in advancing late-stage SBIR-funded technologies for heart, lung, blood, and sleep disorders in small markets toward commercialization and regulatory approval.
Key Information: Only U.S. small businesses with prior SBIR/STTR Phase II awards are eligible; projects must target rare diseases or pediatric populations and require eventual federal regulatory approval.